HOME >> MEDICINE >> NEWS
Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer

CHICAGO, June 2, 2007 -- ALIMTA (pemetrexed for injection) showed additional utility in the treatment of the most diagnosed type of cancer , according to data presented today at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO). Results from a Phase III study suggest that a first-line ALIMTA-based regimen may deliver less toxicity than a commonly used therapy in advanced non-small cell lung cancer (NSCLC). ALIMTA is manufactured and marketed by Eli Lilly and Company.

A prospective, randomized, multicenter Phase III study was conducted to compare ALIMTA plus carboplatin with the commonly used regimen of GEMZAR (gemcitabine HC1 for injection) plus carboplatin (ASCO Abstract # 7517 ). The study, conducted by the Norwegian Lung Cancer Group, enrolled 446 chemonave patients with either stage IIIB or IV NSCLC. The primary purpose of the study was to evaluate if the ALIMTA-carboplatin combination provided increased quality-of-life benefits while offering comparable survival data. As such, the primary endpoint was quality of life (defined in the study as nausea/vomiting; dyspnea or a difficulty in breathing, and; fatigue) and the secondary endpoint was overall survival.

Thus far, 384 patients have been analyzed for toxicity and there were fewer patients in the ALIMTA arm who experienced Grade 3/4 thrombocytopenia or a low platelet level (48 vs. 107, p<.001); leukopenia or a lowering of leukocyte white blood cells (44 vs. 89, p<.001), and; granulocytopenia or a lowering of granulocyte white blood cells (78 vs. 98, p=.02). More patients in the GEMZAR arm received transfusion of platelets (5 vs. 19, p=.02). At this point, no difference in survival has been observed.

The patients in this study received a comparable quality-of-life benefit whether they received ALIMTA and carboplatin or GEMZAR and carboplatin, said Bjrn Henning Grnberg, M.D. of St. Olavs University Hospital in Norway and the studys principal investigat
'"/>

Contact: Neil Hochman
n.hochman@cprworldwideusa.com
212-453-2067
CPR Worldwide
2-Jun-2007


Page: 1 2 3

Related medicine news :

1. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
2. Clinical review -- A psychological approach to the management of irritable bowel syndrome
3. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
4. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
5. Clinical guidelines for blood conservation during cardiac procedures developed
6. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
7. Clinical trial coordinators need more financial conflict-of-interest training
8. Clinical studies evaluate potential treatments for mouth ulcers
9. NIH names Clinical Trial Units for the Microbicide Trials Network
10. Clinical Trials Units selected for newly restructured HIV/AIDS research networks
11. Study in recent issue of Clinical Pediatrics helps pediatricians to understand discipline practices

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2019)... ... 2019 , ... Allegheny Health Network (AHN) has named Kymberly Gyure, MD, Chair ... Medicine in May 2018, previously served as AHN’s Vice Chair of Pathology and Laboratory ... and is also part of the pathology faculty at Drexel University College of Medicine. ...
(Date:12/6/2019)... Calif. (PRWEB) , ... December 06, 2019 , ... Dr. ... Sciences program, recently published research on the health benefits of coconut oil in ... Oil Intake and Its Effects on the Cardiometabolic Profile: A Structured Literature Review,” led ...
(Date:12/5/2019)... ... December 05, 2019 , ... It’s been an ... products that help people embrace, achieve, and maintain a healthy lifestyle to giving ... committed to our mission of impacting world health, so it’s gratifying to look ...
(Date:12/4/2019)... ... December 04, 2019 , ... Healthcare Real Estate Insights™ ... national awards dedicated to recognizing excellence in the areas of healthcare real estate ... nine different categories during the GlobeSt Healthcare Conference today in Scottsdale, Ariz. , ...
(Date:12/2/2019)... , ... December 02, 2019 , ... ... solutions, has worked with EMD Serono, the North American branch of the healthcare ... . This site is designed to educate and inform patients, caregivers, the public, ...
Breaking Medicine News(10 mins):
(Date:12/8/2019)... ... December 08, 2019 , ... A new study from researchers at the ... finds teens overwhelmingly engage with fast food, unhealthy snacks, candy and soft drinks filled ... when teens get stuck inside with family members visiting from out of town. ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... for implementation this month, Kenall is introducing the CSEDOIC luminaire series. CSEDOIC fixtures ... 800 now requires the unpacking of hazardous drugs (HDs) and HD-active pharmaceutical ingredients ...
(Date:12/6/2019)... ... 2019 , ... Kindred Nutrition and Wellness, owned by Amy ... Nutrition and Wellness will continue to focus on Specialized Medical Nutrition Therapy and ... Family Therapy and Yoga. , Kindred Nutrition and Wellness has three dietitians specializing ...
Breaking Medicine Technology:
Cached News: